Ala92 type 2 deiodinase allele increases risk for the development of hypertension

Hypertension

Volumn 49, Issue 3, 2007, Pages 461-466

  Gumieniak, Olga ^a   Perlstein, Todd S ^a   Williams, Jonathan S ^a   Hopkins, Paul N ^b   Brown, Nancy J ^c   Raby, Benjamin A ^a   Williams, Gordon H ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d RFB 2 ^*  (United States)

Author keywords

Genetic predisposition to disease; Genetics; Hypertension; Iodothyronine deiodinase type 2; Thyroid hormones

Indexed keywords

ALANINE; IODOTHYRONINE DEIODINASE TYPE 2; THREONINE; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EUTHYROIDISM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; IODIDE PEROXIDASE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33847082534     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000256295.72185.fd     Document Type: Article

References (37)

1. Bhargava HN, Das S, Bansinath M. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats. Peptides. 1987;8:231-235.
2. Bruhn TO, Jackson IM. Abnormalities of the thyroid hormone negative feedback regulation of TSH secretion in spontaneously hypertensive rats. Regul Pept. 1992;38:221-230.
3. Garcia SI, Dabsys SM, Martinez VN, Delorenzi A, Santajuliana D, Nahmod VE, Finkielman S, Pirola CJ. Thyrotropin-releasing hormone hyperactivity in the preoptic area of spontaneously hypertensive rats. Hypertension. 1995;26:1105-1110.
4. Garcia SI, Alvarez AL, Porto PI, Garfunkel VM, Finkielman S, Pirola CJ. Antisense inhibition of thyrotropin-releasing hormone reduces arterial blood pressure in spontaneously hypertensive rats. Hypertension. 2001;37:365-370.
5. Sowers JR, Tempel G, Resch G, Colantino M. Pituitary response to TRH and LHRH in spontaneously hypertensive rats. Proc Soc Exp Biol Med. 1978;159:397-399.
6. Suzuki S, Pilowsky P, Minson J, Arnolda L, Llewellyn-Smith I, Chalmers J. Antisense to thyrotropin releasing hormone receptor reduces arterial blood pressure in spontaneously hypertensive rats. Circ Res. 1995;77:679-683.
7. Garcia SI, Porto PI, Dieuzeide G, Landa MS, Kirszner T, Plotquin Y, Gonzalez C, Pirola CJ. Thyrotropin-releasing hormone receptor (TRHR) gene is associated with essential hypertension. Hypertension. 2001;38:683-687.
8. Gumieniak O, Perlstein TS, Hopkins PN, Brown NJ, Murphey LJ, Jeunemaitre X, Hollenberg NK, Williams GH. Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab. 2004;89:3455-3461.
9. Iqbal A, Figenschau Y, Jorde R. Blood pressure in relation to serum thyrotropin: the Tromso study. J Hum Hypertens. 2006;20:932-936.
10. Koizumi Y, Aizawa T, Tawata M, Yamada T, Yamori Y. Effect of normalization of hypometabolic state on blood pressure in spontaneously hypertensive rats and in patients with essential hypertension. J Am Geriatr Soc. 1976;24:454-457.
11. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411-414.
12. Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid. 1996;6:505-512.
13. Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg. 1997;85:734-738.
14. Gumieniak O, Hurwitz S, Perlstein TS, Ngumezi UC, Hopkins PN, Jeunemaitre X, Williams GH. Aggregation of high-normal thyroidstimulating hormone in hypertensive families. J Clin Endocrinol Metab. 2005;90:5985-5990.
15. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23:38-89.
16. Nguyen TT, Chapa F, DiStefano JJ, III. Direct measurement of the contributions of type I and type II 5′-deiodinases to whole body steady state 3,5,3′-triiodothyronine production from thyroxine in the rat. Endocrinology. 1998;139:4626-4633.
17. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab. 2003;88:2880-2888.
18. Mizuma H, Murakami M, Mori M. Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res. 2001;88:313-318.
19. Hopkins PN, Hunt SC, Jeunemaitre X, Smith B, Solorio D, Fisher ND, Hollenberg NK, Williams GH. Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation. 2002;105:1921-1927.
20. Williams GH, Fisher ND, Hunt SC, Jeunemaitre X, Hopkins PN, Hollenberg NK. Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension. Kidney Int. 2000;57:1404-1407.
21. Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK, Seely EW. Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens. 2001;19:99-105.
22. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR, Celi FS. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes. 2002;51:880-883.
23. Lalouel JM. Large-scale search for genes predisposing to essential hypertension. Am J Hypertens. 2003;16:163-166.
24. Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet. 2003;361:1629-1641.
25. Williams GH. Genetic factors associated with volume-sensitive hypertension. Mol Cell Endocrinol. 2004;217:41- 44.
26. Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26:704-728.
27. Klein I, Ojamaa K. The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:777-782 .
28. Celi FS, Canettieri G, Mentuccia D, Proietti-Pannunzi L, Fumarola A, Sibilla R, Predazzi V, Ferraro M, Andreoli M, Centanni M. Structural organization and chromosomal localization of the human type II deiodinase gene. Eur J Endocrinol. 2000;143:267-271.
29. Bartha T, Kim SW, Salvatore D, Gereben B, Tu HM, Harney JW, Rudas P, Larsen PR. Characterization of the 5′-flanking and 5′-untranslated regions of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology. 2000;141:229-237.
30. Croteau W, Davey JC, Galton VA, St Germain DL. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest. 1996;98:405- 417.
31. Salvatore D, Bartha T, Harney JW, Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 1996;137:3308 -3315.
32. Ezaki O. Regulatory elements in the insulin-responsive glucose transporter (GLUT4) gene. Biochem Biophys Res Commun. 1997;241:1-6.
33. Torrance CJ, Devente JE, Jones JP, Dohm GL. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology. 1997;138:1204-1214.
34. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643-1649.
35. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
36. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 1995;13:1457-1462.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.